Indaptus Therapeutics
INDP
18 hedge funds and large institutions have $2.15M invested in Indaptus Therapeutics in 2020 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 3 reducing their positions, and 11 closing their positions.
2,200% more call options, than puts
Call options by funds: $46K | Put options by funds: $2K
133% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 3
119% more capital invested
Capital invested by funds: $979K → $2.15M (+$1.17M)
25% less funds holding
Funds holding: 24 → 18 (-6)
55% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 11
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MIH
Meitav Investment House
Bene-Beraq,
Israel
|
+$471K |
| 2 |
VF
Virtu Financial
New York
|
+$259K |
| 3 |
AI
AdvisorShares Investments
Bethesda,
Maryland
|
+$219K |
| 4 |
Millennium Management
New York
|
+$183K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$171K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
IWC
Integrated Wealth Concepts
Waltham,
Massachusetts
|
-$104K |
| 2 |
HIIFS
Harel Insurance Investments & Financial Services
Ramat Gan,
Israel
|
-$99K |
| 3 |
Squarepoint
New York
|
-$20K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$16.6K |
| 5 |
UCFA
United Capital Financial Advisors
Irving,
Texas
|
-$7K |
INDP Hedge Fund Activity: Q4 2020 in Review
18 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Indaptus Therapeutics (INDP) for Q4 2020, worth a combined $2.15M — up 119% from $979K a quarter earlier.
Sellers outnumbered buyers: 11 funds closed out of INDP and 5 opened new positions — a net loss of 6 holders — while 3 trimmed existing stakes and 7 added.
The largest buyer was Meitav Investment House, adding an estimated $471K. The largest seller was Integrated Wealth Concepts, exiting entirely with an estimated $104K sold.
- 18 institutional investors held Indaptus Therapeutics (INDP) as of Q4 2020, down from 24 in Q3 2020.
- Funds reported $2.15M of Indaptus Therapeutics stock for Q4 2020, up 119% quarter-over-quarter.
- 5 funds opened new Indaptus Therapeutics positions in Q4 2020 and 11 closed out, a net change of -6 holders.
- The largest Indaptus Therapeutics buyer in Q4 2020 was Meitav Investment House, an estimated $471K added.
- The largest Indaptus Therapeutics seller in Q4 2020 was Integrated Wealth Concepts, an estimated $104K sold.
Based on aggregated 13F filings for Q4 2020.